Research landing page

Our ALS research resources to accelerate discovery 
to find a cure.

For the first time in the history of the disease, through our research cores, scientists gain access to critical ALS research tools and resources with no strings attached.

Our new Target ALS Research Cores are comprised of a network of academic centers and contract research organizations that provide needed tools and resources to scientists. By supporting researchers with essential resources, we reduce barriers to advancement and accelerate the path to breakthroughs—for a future with a cure.

6

Research cores

100+

Scientists supported

Icon

Human Postmortem Tissue Core

Access CNS tissue from ALS and control cases with detailed, de-identified clinical and demographic data.

Icon

Target ALS Data Engine

Explore whole genome and whole tissue RNA sequences datasets from postmortem ALS cases.

Icon

Stem Cell Core

Access iPS lines from ALS (familial and sporadic) and control cases.

Icon

Animal Models Core

We are looking for collaborators to develop new animal models and to generate multi-omic datasets in mouse models to share with the community.

Icon

Reagents Core

Use our curated panel of high-quality monoclonal and polyclonal antibodies for ALS studies.

Icon

Longitudinal Biofluids Core

Access longitudinally-collected biofluids collected over time from ALS and control cases with linked clinical, demographic, and genomic data.

Map Goes here

Description goes here

Fueling discovery, together

Historically, ALS researchers have cited poor quality, lack of standardization, limited accessibility and the high cost of critical tools, and resources as a major barrier to advancing their ideas. We tackled these issues by creating entirely new Target ALS Research Cores. Breakthroughs in ALS research depend on collaboration and access. By sharing these resources freely with the scientific community, Target ALS accelerates the path to a cure.

“Lorem ipsum dolor sit amet, consectetur adipiscing elit. Netus ornare dolor maece. Ut enim ad minim veniam, quis nostrud exercitation.”

First name LastnameTitle goes here and here and here and here

Frequently asked questions

Optional subtext goes here up to 150 characters. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.

““Lorem ipsum dolor sit amet, consectetur adipiscing elit. Netus ornare dolor maece. Ut enim ad minim veniam, quis nostrud exercitation.””

Author

FIRSTNAME LASTNAME

Title goes here and here and u2028here and here

  1. to effective treatments and inspiring hope for everyone affected 
by ALS.
  2.  Our model is accelerating the path
    1. to effective treatments and inspiring hope for everyone affected
    2. 
by ALS. Our model is accelerating the path to
      1. effective treatments and inspiring hope for everyone affected 
by ALS.
      2.  Our model is accelerating the path to effective treatments and inspiring hope for everyone affected 
by ALS.
        1.  Our model is accelerating the path to effective treatments and inspiring hope for everyone affected 
by ALS.
        2.  Our model is accelerating the path to effective treatments and inspiring hope for everyone affected 
by ALS.
    3. test

 Our model is accelerating the path

LWe’re changing the future of ALS research by breaking down

We’re changing the future of ALS research by breaking down barriers and investing in science that moves faster than this devastating disease. Our mode

campaign